Vistagen Therapeutics, Inc. (VTGN)

NASDAQ: VTGN · Real-Time Price · USD

3.960

+0.070 (1.80%)

At close: Oct 7, 2025, 4:00 PM EDT

4.060

+0.100 (2.53%)

Pre-market: Oct 8, 2025, 4:46 AM EDT

Revenue by Product

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2016	2013 - 2015
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '16 Mar 31, 2016	2013 - 2015
Central Nervous System Therapies	1.06M	Log In	Log In	Log In	Log In	Upgrade
Central Nervous System Therapies Growth	-568.10%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2016	2013 - 2015
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '16 Mar 31, 2016	2013 - 2015
United States	1.06M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-568.10%	Log In	Log In	Log In	Log In	Upgrade